Nova Eye Medical Ltd has released a press release.
2RT Pivotal Study and Regulatory Pathway
Filed with ASX ·
Watch Nova Eye Medical's latest callNova Eye Medical (ASX:EYE) Q4 2026 Earnings Call · Replay · Aug 3Read the transcript of Nova Eye Medical (ASX:EYE) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
In the deck
Earlier from Nova Eye Medical
- Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
- Investor presentation Half Year Results 31 December 2021
- Half year results discussion
- Glaucoma Sales Update
- EYE AGM Presentation
Later from Nova Eye Medical
- AlphaRet Investor Presentation
- iTrack Advance Commercial Roll-Out Commenced
- Appendix 4E and Annual Report FY22
- Investor Presentation FY22
- Results Announcement FY22
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical